Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer

Starting soon · Not applicable

Conditions studied: Pancreatic Cancer

In brief

To determine the efficacy of a 12-week supervised, hypertrophy-oriented strength training program in preserving skeletal muscle mass, physical function, and quality of life in patients with unresectable pancreatic cancer compared to standard care.

Key facts

Study ID

NCT07470268

Run by

Universidad Europea de Madrid

People needed

10

Starts

2026-09-01

Expected to finish

2027-09-01

Last updated by the study team

2026-03-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of locally advanced or metastatic unresectable pancreatic cancer
• Undergoing chemotherapy or immunotherapy treatment
• Age ≥ 18 years
• ECOG score ≤ 2

You may not qualify if…

• Any relative or absolute contraindication that prevents the performance of training or physical tests.
• Diagnosis of other types of primary cancer
• Inability to understand Spanish for proper comprehension of the informed consent and questionnaires

Where it is running

• Universidad Europea de Madrid — Madrid, Madrid, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.